TY  - GEN
AU  - Kim,Mi-Kyung
AU  - Chae,Yu Na
AU  - Kim,Hae Sun
AU  - Choi,Song-hyen
AU  - Son,Moon Ho
AU  - Kim,Soon Hoe
AU  - Kim,Jin Kwan
AU  - Moon,Ho Sang
AU  - Park,Sang Kuk
AU  - Shin,Young Ah
AU  - Kim,Jae Gyu
AU  - Lee,Chun Ho
AU  - Lim,Joong In
AU  - Shin,Chang Yell
TI  - PAR-1622 is a selective peroxisome proliferator-activated receptor gamma partial activator with preserved antidiabetic efficacy and broader safety profile for fluid retention
SN  - 0253-6269
PY  - 2009///0629
KW  - Adipogenesis
KW  - drug effects
KW  - Administration, Oral
KW  - Animals
KW  - Blood Glucose
KW  - Blood Volume
KW  - Cells, Cultured
KW  - Diabetes Mellitus, Type 2
KW  - drug therapy
KW  - Disease Models, Animal
KW  - Dose-Response Relationship, Drug
KW  - Drug Partial Agonism
KW  - Genes, Reporter
KW  - Humans
KW  - Hypoglycemic Agents
KW  - administration & dosage
KW  - Isoxazoles
KW  - Male
KW  - Mesenchymal Stem Cells
KW  - Mice
KW  - Mice, Inbred ICR
KW  - PPAR gamma
KW  - agonists
KW  - Propionates
KW  - Rosiglitazone
KW  - Thiazolidinediones
KW  - pharmacology
KW  - Thiophenes
KW  - Transfection
KW  - Water-Electrolyte Balance
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s12272-009-1511-8
ER  -